[{"Assets_0_Q2_USD":21485900000.0,"CIK":"872589","Country":"United States","EarningsPerShareBasic_1_Q2_USD":29.51,"EarningsPerShareBasic_2_Q2_USD":40.06,"EarningsPerShareDiluted_1_Q2_USD":27.97,"EarningsPerShareDiluted_2_Q2_USD":38.07,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"77738004554.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":1295200000.0,"NetIncomeLossConverted_1_Q2_USD":3098900000.0,"NetIncomeLossConverted_2_Q2_USD":4214100000.0,"OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","RevenuesConverted_1_Q2_USD":5138500000.0,"RevenuesConverted_2_Q2_USD":7667200000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquity_0_Q2_USD":15127300000.0,"Ticker":"REGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":110800000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":110700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":105000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":105200000.0,"filed":"20210805","footnote":"nan","form":"10-Q","fp":"Q2","fy":"2021.0","name":"REGENERON PHARMACEUTICALS, INC.","period":"20210630","qtrs":"0","uom":"USD"}]